⌘K

Login Start Free

Home/Insiders/Dandekar Atul

DA

SEC Insider//CIK 0002050167

Dandekar Atul

CIK 00020501671 companySOUTH SAN FRANCISCO, CA

Transactions

8

Companies

1

Filings

2

CIK

0002050167

Recent Transactions

8 trades

Exercise/Conversion
Maze Therapeutics, Inc.$MAZE
Stock Option (Right to Buy)
2025-12-30−100→ 74,143 total
Exercise/Conversion
Maze Therapeutics, Inc.$MAZE
Common Stock
2025-12-30$10.42/sh+100→ 10,603 total
Sale
Maze Therapeutics, Inc.$MAZE
Common Stock
2025-12-30$40.36/sh−100→ 10,503 total
Sale
Maze Therapeutics, Inc.$MAZE
Common Stock
2025-12-29$41.13/sh−6,035→ 10,503 total
Exercise/Conversion
Maze Therapeutics, Inc.$MAZE
Stock Option (Right to Buy)
2025-12-29−72,400→ 74,243 total
Exercise/Conversion
Maze Therapeutics, Inc.$MAZE
Common Stock
2025-12-29$10.42/sh+72,400→ 82,903 total
Sale
Maze Therapeutics, Inc.$MAZE
Common Stock
2025-12-29$40.51/sh−66,365→ 16,538 total
Award
Maze Therapeutics, Inc.$MAZE
Restricted Stock Units
2025-09-22+25,000→ 25,000 total

Companies

1

Maze Therapeutics, Inc.
CSBO
$MAZE

Recent Filings

2

Address

C/O MAZE THERAPEUTICS, INC. 171 OYSTER POINT BOULEVARD, SUITE 300

SOUTH SAN FRANCISCO, CA, 94080

View on SEC.gov